Ruibing Deng

Dr. Ruibing Deng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Heliyon
Verified
Journal Article
Open access
YHYue Hu
Yue Hu
XLXiao-Hua Lan
Xiao-Hua Lan
YCyanjie Cao
yanjie Cao
JDJing-Qi Duan
Jing-Qi Duan
QRQi-Tao Ren
Qi-Tao Ren
RDRuibing Deng
Ruibing Deng
The number of centenarians with cancer is increasing as the global population ages. The diagnosis and treatment for centenarians with tumor sometimes are specific, and there are currently less appropriate guidelines as references. We report a 104-year-old man with asymptomatic primary liver cancer (PLC) whose family decided to receive conservative and palliative care. The patient has been followed up for 27 months. He has been mainly received Chinese herbal medicine (CHM), nutritional support and thymalfasin injection intermittently, etc. During the 27-month follow-up, the patient has showed good compliance and tolerance without any complications of the tumor. Conclusion: Individualized palliative care and complementary medicine, based on multidisciplinary evaluation, traditional Chinese medicine, consultation with patients and their families about treatment options, etc., may help improve the life quality of centenarians with end-stage tumors.